Providencia Biosciences Private Limited

Produces aqua health care products such as Ammonia Zyme and Pond Zyme.

2018 | Kanchipuram, Tamil Nadu (India) | Active
Last Updated: January 11, 2025

Providencia Biosciences Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 0.60 M
  • Revenue Growth -16.75%
  • Profit Growth -32.34%
  • Ebitda -14.82%
  • Net Worth 27.69%
  • Total Assets -0.68%

About Providencia Biosciences

Providencia Biosciences Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 April 2018 (Six years and ten months 2 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.

The Company is engaged in the Agriculture Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.

The company currently has active open charges totaling ₹0.60 M.

Ashok Godavarti and Yesudhasan Justin serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U74999TN2018PTC121988

  • Company No.

    121988

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Apr 2018

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chennai

Industry

Agriculture

Who are the key members and board of directors at Providencia Biosciences?

Board Members (2)

Name Designation Appointment Date Status
Ashok Godavarti Country flag representing In Director 09-Apr-2018 Current
Yesudhasan Justin Country flag representing In Director 09-Apr-2018 Current

Financial Performance of Providencia Biosciences.

Providencia Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.75% decrease. The company also saw a substantial fall in profitability, with a 32.34% decrease in profit. The company's net worth Soared by an impressive increase of 27.69%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
-16.75%
Revenue from Operations
-16.81%
Total Assets
-0.68%
Profit or Loss
-32.34%
Net Worth
27.69%
EBITDA
-14.82%

What is the Ownership and Shareholding Structure of Providencia Biosciences?

In 2021, Providencia Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0.60 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 0.06 Cr

Latest Charge Details

Date Lender Amount Status
23 Jun 2021 Axis Bank Limited ₹0.60 M Open

How Many Employees Work at Providencia Biosciences?

Unlock and access historical data on people associated with Providencia Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Providencia Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Providencia Biosciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Providencia Biosciences

Recent activity within the organization

  • Annual General Meeting

    Providencia Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Providencia Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.

    31 Mar 2024

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 0.60 M with Charge ID 100453558 was registered on 23 Jun 2021.

    23 Jun 2021

  • Director Appointment

    Ashok Godavarti was appointed as a Director was appointed as a Director on 09 Apr 2018 & has been associated with this company since 6 years 10 months .

    09 Apr 2018

  • Director Appointment

    Yesudhasan Justin was appointed as a Director was appointed as a Director on 09 Apr 2018 & has been associated with this company since 6 years 10 months .

    09 Apr 2018

  • Company Incorporation

    Providencia Biosciences Private Limited was registered on 09 Apr 2018 with Roc Chennai & aged 6 years 10 months as per MCA records.

    09 Apr 2018

Frequently asked questions

  • Providencia Biosciences Private Limited was incorporated on 09 Apr 2018.

  • The authorized share capital of Providencia Biosciences Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Providencia Biosciences Private Limited.

    • Ashok Godavarti
    • Yesudhasan Justin
  • As per Ministry of Corporate Affairs (Mca), the registered address of Providencia Biosciences Private Limited is 362A/5 Ground Floor Jeevanandam Street Sadhananthapuram, India, Chennai, Tamil Nadu, 600063.

  • The corporate identification number (CIN) of Providencia Biosciences Private Limited is U74999TN2018PTC121988 and the company number is 121988 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Providencia Biosciences Private Limited is https://www.providenciabiosciences.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Providencia Biosciences Private Limited has fallen by -16.75%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Providencia Biosciences Private Limited has experienced an upsurge of 27.69%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Providencia Biosciences Private Limited amount to ₹ 0.60 M.

  • The most recent Balance Sheet for Providencia Biosciences Private Limited was filed with the ROC on 31 Mar 2024.